Navigation Links
Improving care and knowledge in translational research to fight breast cancer

Berlin, 15 April 2008 -- European breast cancer specialists have taken a significant step forward in the fight against breast cancer by bringing together world leaders in breast cancer research and treatment at an innovative European scientific meeting, IMPAKT (IMProving cAre and Knowledge in Translational research).

The first IMPAKT meeting, to be held 7-9 May 2009 in Brussels, Belgium, is designed to present and discuss advances in translational research and ways to quickly transform laboratory discoveries into tools that clinicians can use to help make decisions about the way they treat patients in their daily practice.

With breast cancer being the most prevalent cancer in women worldwide, collaboration to fight this devastating disease is necessary. IMPAKT fills an urgent need within the oncology community to coordinate efforts to bring the fruits of advances in science and technology to the patients bedside, says Dr. Martine Piccart, Co-Chair of the meeting.

Building on existing high-level international research collaborations developed by the Breast International Group (BIG) and combining this with the other partners reputations for organizing high quality scientific and educational meetings, IMPAKT will offer a platform for discussing the latest developments in translational research, biomedical technologies and novel therapeutics in breast cancer, adds Dr. Jos Baselga, conference Co-Chair with Dr. Piccart.

IMPAKT is being launched by BIG and the European Society for Medical Oncology, in collaboration with the St. Gallen Primary Therapy of Early Breast Cancer Conference; the three European Breast Cancer Conference partners, which are The European Organisation for Research and Treatment of Cancer Breast Cancer Group, The European Society of Breast Cancer Specialists, and Europa Donna The European Breast Cancer Coalition; and with the support of the European School of Oncology.

We have succeeded in creating a model of direct collaboration between professional medical societies, research groups and cancer patient organizations. This underlines the IMPAKT organizers commitment to stimulate much needed communication across basic, translational and clinical research in breast cancer, said Dr. Baselga.

The meeting will encourage researchers and clinicians to share best practices and provide participants with information on the skills and techniques needed today to apply cutting-edge research to the clinical setting.

While IMPAKT is primarily a scientific meeting, it also includes a full-day training course for young oncologists to help them better understand the new translational research technologies. They will also gain insights into future opportunities in research, and have the possibility to link up with the international network of breast cancer experts.


Contact: Gracemarie Bricalli
European Society for Medical Oncology

Related biology news :

1. Improving detection of nuclear smuggling goal of computer model of mechanical engineer
2. UV light improving chances of fighting cancer
3. Improving science, technology in Africa is aim as G-8, African, UN experts convene in Berlin
4. A tall story: New research adds to growing body of knowledge of genetics of height
5. A call to infuse scientific knowledge into the human experience
6. Rutgers scientists research reveals critical knowledge about the nervous system
7. UD hosts conference on knowledge-based partnerships Nov. 2
8. Fossil data plugs gaps in current knowledge, study shows
9. Translational research patented first experimental treatment against idiopathic pulmonary fibrosis
10. AACR, BCRF award inaugural grants in translational breast cancer research
11. NIH awards nearly $23M to University of Chicago for translational research
Post Your Comments:
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has ... to provide preclinical development services to the National Cancer ... SRI will provide scientific expertise, modern testing and support ... of preclinical pharmacology and toxicology studies to evaluate potential ... --> The PREVENT Cancer Drug Development Program is ...
(Date:10/29/2015)... Calif. , Oct. 29, 2015  The J. ... new report titled, "DNA Synthesis and Biosecurity: Lessons Learned ... the Department of Health and Human Services guidance for ... in 2010. --> ... it also has the potential to pose unique biosecurity ...
(Date:10/29/2015)... 2015  Rubicon Genomics, Inc., today announced an ... its DNA library preparation products, including the ThruPLEX ... Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for ... libraries for liquid biopsies--the analysis of cell-free circulating ... in cancer and other conditions. Eurofins Scientific is ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... , November 24, 2015 ... new market research report "Oligonucleotide Synthesis Market by Product ... (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical ... published by MarketsandMarkets, the market is expected to reach ... in 2015, at a CAGR of 10.1% during the ...
(Date:11/24/2015)... November 24, 2015 --> ... research report released by Transparency Market Research, the global ... a CAGR of 17.5% during the period between 2014 ... - Global Industry Analysis, Size, Volume, Share, Growth, Trends ... prenatal testing market to reach a valuation of US$2.38 ...
(Date:11/24/2015)... ... November 24, 2015 , ... In ... paramount. Insertion points for in-line sensors can represent a weak spot where leaking ... 781/784 series of retractable sensor housings , which are designed to tolerate extreme ...
(Date:11/24/2015)... , Nov. 24, 2015 Capricor Therapeutics, ... focused on the discovery, development and commercialization of first-in-class ... Chief Executive Officer, is scheduled to present at the ... at 10:50 a.m. EST, at The Lotte New York ... . . --> ...
Breaking Biology Technology: